Cancer of the Urethra is a condition where malignant cells grow in the urethra, the tube that passes urine from the bladder to the outside of the body. The word 'urethra' is generally spelled as /juˈriːθrə/ in IPA phonetic transcription, with the stress on the second syllable. 'Cancer' is pronounced as /ˈkænsər/, with the stress on the first syllable. Although the spelling of the word 'urethra' might seem challenging, it is important for healthcare professionals to be precise in their language when discussing medical conditions.
Cancer of the urethra refers to a malignant condition that develops in the cells of the urethra, which is the tube responsible for carrying urine from the bladder out of the body. The urethra plays a crucial role in both urinary and reproductive functions in males and females.
Cancer of the urethra is considered a rare form of cancer that occurs more frequently in men than women. This type of cancer can be categorized into two main types: primary urethral cancer, which originates in the cells lining the urethra, and secondary or metastatic urethral cancer, which occurs when cancer cells from nearby organs or tissues spread to the urethra.
The exact cause of cancer of the urethra is often unknown, but certain factors may increase the risk of developing this condition. These factors include advanced age, chronic inflammation of the urethra, history of sexually transmitted infections, tobacco use, and exposure to certain chemicals or environmental factors.
Symptoms of cancer of the urethra may include blood in the urine, frequent urination, painful or burning urination, urinary blockage, discharge from the urethra, and in advanced stages, a visible mass or lump near the urethral opening.
Treatment options for cancer of the urethra depend on various factors such as the stage and location of the tumor, as well as the overall health of the patient. Treatment may include surgery to remove the tumor, radiation therapy, chemotherapy, or a combination of these modalities. Regular follow-up appointments and monitoring are crucial to assess treatment response and detect any signs of recurrence or metastasis.